You are here

North America $4.14 bN Genome Editing Market to 2025

DUBLIN, May 14, 2019 /PRNewswire/ -- The "North America Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology, Application, End User, and Country" report has been added to ResearchAndMarkets.com's offering.

The North America genome editing market is expected to reach US$ 4,148.1 Mn in 2025 from US$ 1,234.5 Mn in 2017. The market is estimated to grow with a CAGR of 17.2% from 2018-2025.

The growth of the genome editing market is primarily attributed to the rise in the production of genetically modified crops and rising prevalence of the genetic diseases. However, the stringent regulatory framework and limitations in genome editing are likely to pose a negative impact on the market growth. On the other hand, emerging markets for precision and regenerative medicines is likely to have a positive impact on the growth of the North America genome editing market in the coming years.

The genome editing has proved itself to be the most promising way of feeding the fast growing population across the world. The changes in the climatic conditions due to the global warming and others conditions such as droughts floods are witnessed more across the world. Therefore, the feeding the rising population is question among the people across the world. Due to the genome editing the concerns are being reduced to a great level, the two types of the genetically modified crops are widely grown. Firstly, these crops are altered in a ways that they are not affected by the herbicide glyphosate. Secondly, crops are produced to protect themselves from the insecticides.

The advantages of the genetically modified crops includes diseases resistance, improvement of the photosynthesis, improvement of the nutrition, and more. The genetic modification helps to enhance the productivity without hampering the health of the crops. In addition, for the genetically modified crops the limited resources are required and it require less or no pesticides for its growth. The time required for the growth of the genetically modified crops is less, therefore these are highly preferred crops in the western world. The demand for the genetically modified crops is rising in the eastern region due to the benefits offered by these crops.

According to the International Service For The Acquisition Of Agri-Biotech Applications (ISAAA), 2017 statistics, 19 developing countries have planted 53% which is approximately to 100.6 million hectares of the global biotech hectares, whereas the 5 industrial countries have took the 47% which is near about 89.2 million hectares share. The trend of growing genetically modified crop is expected to grow in the coming future.

In 2017, the CRISPR segment segment held a largest market share of 53.6% of the genome editing market, by technology. This segment is also expected to dominate the market in 2025 owing to the simple, fast and accurate property of the CRISPR. Moreover, the TALENs segment is anticipated to witness the significant growth rate of 17.1% during the forecast period, 2018 to 2025 owing to the properties provided by the TALENs the market for it is expected to rise in the coming near future.

North America genome editing market, based on application was segmented into genetic engineering, cell line engineering and others. The cell line engineering segment is anticipated to grow at a CAGR of 18.0% during the forecast period. Moreover, the genetic engineering segment is expected to grow at the significant rate during the coming years owing to its sub segments such as animal genetic engineering and plant genetic engineering that are being carried out extensively.

In 2017, the biotechnology & pharmaceutical companies segment held a largest market share of 61.2% of the genome editing market, by end user. This segment is also expected to dominate the market in 2025 owing to the advantages of the CRISPR, the companies have enhanced their research and development for the drug discoveries that can treat various diseases. Hence, the market is likely to propel in the coming years.

Some of the major primary and secondary sources for genome editing included in the report are, Contract Research Organizations (CRO), United States Department of Agriculture (USDA), National Institutes of Health (NIH), Abu Dhabi Fund for Development (ADFD), Ministry of Science and Technology (MST), International Service For The Acquisition Of Agri-Biotech Applications (ISAAA), Food and Drug Administration (FDA), Department of Biotechnology (DBT) and others.

Key Topics Covered:

Part 1. Introduction
1.1 Scope Of The Study
1.2 Report Guidance

Part 2. North America Genome Editing Testing Market - Key Takeaways

Part 3. North America Genome Editing Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.3 Pest Analysis

Part 4. North America Genome Editing Market- Key Market Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

Part 5. Genome Editing Market - North America Analysis
5.1 North America Genome Editing Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
5.4 Expert Opinions

Part 6. North America Genome Editing Market Analysis - By Technology
6.1 Overview
6.2 North America Genome Editing Market, By Technology, 2017 & 2025 (%)
6.3 North America Genome Editing Market Revenue And Forecasts To 2025, By Technology (Us$ Mn)
6.4 Transcription Activator-Like Effector Nucleases (TALENS) Market
6.5 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market
6.6 Zinc Finger Nucleases (ZFNS) Market
6.7 Antisense Rna Market
6.8 Others Market

Part 7. North America Genome Editing Market Analysis - By Application
7.1 Overview
7.2 North America Genome Editing Market, By Application, 2017 & 2025 (%)
7.3 North America Genome Editing Market Revenue And Forecasts To 2025, By Application (Us$ Mn)
7.4 Genetic Engineering Market
7.5 Cell Line Engineering Market
7.6 Others Market

Part 8. North America Genome Editing Market Analysis - By End User
8.1 Overview
8.2 North America Genome Editing Market, By End User, 2017 & 2025 (%)
8.3 North America Genome Editing Market Revenue And Forecasts To 2025, By End User (Us$ Mn)
8.4 Biotechnology & Pharmaceutical Companies Market
8.5 Academic & Government Research Organizations Market
8.6 Contract Research Organization Market

Part 9. North America Genome Editing Market Revenue And Forecasts To 2025

Part 10. Genome Editing Market-Key Company Profiles

  • Transposagen Biopharmaceuticals, Inc.
  • Integrated DNA Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • GenScript
  • Lonza
  • Horizon Discovery Group plc
  • Sangamo Therapeutics, Inc.
  • New England Biolabs
  • Editas Medicine
  • Merck KGaA

For more information about this report visit https://www.researchandmarkets.com/r/bszcsy

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/north-america-4-14-bn-genome-editing-market-to-2025--300848791.html

SOURCE Research and Markets